Back to Dashboard
REGN · Healthcare

REGENERON PHARMACEUTICALS

USA Healthcare Filing: 2025-12-31
Smart-money confidence · 1 of 3 sources firing
Weak — few signals

No standout activity across the feeds we track.

Hedge funds
50
Congress
0
Insiders
50
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
Limited info. REGENERON PHARMACEUTICALS is not currently in our model portfolio, but 9 tracked investors hold it. We're showing what we know from their latest 13F filings.
Market cap
$71.2B
Industry
Biotechnology
Exchange
NasdaqGS
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases; and cancer, hematologic conditions. It also offers EYLEA injections for wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; retinopathy of prematurity; Dupixent injection to treat atopic dermatitis and asthma;…
9
Investors
0
New positions
4
Increasing
5
Decreasing
0
Unchanged
Price History
Loading price data...
Return: High: Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Southeastern Asset Mgmt (Longleaf)
Trust weight: 1.2×
Increased +15%
% of portfolio
5.7%
Position change
+15%
5.7% of Southeastern Asset Mgmt's portfolio
AQR Capital Management
Trust weight: 1.0×
Increased +38%
% of portfolio
0.4%
Position change
+38%
0.4% of AQR Capital Management's portfolio
Point72 (Steve Cohen)
Trust weight: 1.1×
Increased +30%
% of portfolio
0.3%
Position change
+30%
0.3% of Point72's portfolio
Millennium Management (Englander)
Trust weight: 1.0×
Increased +89%
% of portfolio
0.2%
Position change
+89%
0.2% of Millennium Management's portfolio
Gotham Asset Mgmt (Greenblatt)
Trust weight: 1.1×
Decreased −5%
% of portfolio
0.2%
Position change
−5%
0.2% of Gotham Asset Mgmt's portfolio
Bridgewater Associates (Dalio)
Trust weight: 1.3×
Decreased −69%
% of portfolio
0.2%
Position change
−69%
0.2% of Bridgewater Associates's portfolio
D.E. Shaw & Co
Trust weight: 1.0×
Decreased −82%
% of portfolio
0.1%
Position change
−82%
0.1% of D.E. Shaw & Co's portfolio
Citadel Advisors
Trust weight: 1.0×
Decreased −37%
% of portfolio
0.1%
Position change
−37%
0.1% of Citadel Advisors's portfolio
ARK Invest (Cathie Wood)
Trust weight: 1.3×
Decreased −99%
% of portfolio
0.0%
Position change
−99%
0.0% of ARK Invest's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to REGENERON PHARMACEUTICALS
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell REGENERON PHARMACEUTICALS or any security.

Get the Weekly Update

Every Sunday, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime
© 2026 Bogen Capital  ·  Not financial advice  ·  Data delayed up to 135 days Methodology  ·  Contact  ·  API